{
    "clinical_study": {
        "@rank": "4682", 
        "arm_group": {
            "arm_group_label": "Cohort"
        }, 
        "brief_summary": {
            "textblock": "This multicenter observational study will evaluate the use of RoActemra/Actemra\n      (tocilizumab) in monotherapy in patients with active moderate to severe rheumatoid arthritis\n      unable to use methotrexate. Eligible patients initiated on RoActemra/Actemra treatment will\n      be followed for 6 months."
        }, 
        "brief_title": "An Observational Study of RoActemra/Actemra (Tocilizumab) in Monotherapy in Patients With Rheumatoid Arthritis", 
        "completion_date": {
            "#text": "September 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Rheumatoid Arthritis", 
        "condition_browse": {
            "mesh_term": [
                "Arthritis", 
                "Arthritis, Rheumatoid"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Adult patients, >/= 18 years of age\n\n          -  Moderate to severe rheumatoid arthritis according to the revised (1987) ACR criteria\n\n          -  Patients who for any reason do not take methotrexate and for whom the treating\n             physician has made a decision to prescribe RoActemra/Actemra as monotherapy; patients\n             who commenced RoActemra/Actemra as monotherapy within 8 weeks prior to the enrolment\n             visit may be included\n\n          -  Concomitant treatment with non-steroidal anti-inflammatory drug (NSAID) or\n             corticosteroids (orally or intra-articularly) is allowed\n\n        Exclusion Criteria:\n\n          -  Patients who have received RoActemra/Actemra more than 8 weeks prior to enrolment\n             visit\n\n          -  Previous RoActemra/Actemra treatment in a clinical trial or for compassionate use\n\n          -  Concomitant DMARD treatment for rheumatoid arthritis (e.g. hyroxychloroquine,\n             sulfasalazine, methotrexate, leflunomide, gold compounds, cyclosporine)\n\n          -  Treatment with any investigational agent within 4 weeks (or 5 half-lives of\n             investigational agent, whichever is longer) before starting RoActemra/Actemra\n             treatment\n\n          -  History of autoimmune disease or any joint inflammatory disease other than rheumatoid\n             arthritis"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Patients with active moderate to severe rheumatoid arthritis unable to use methotrexate"
            }
        }, 
        "enrollment": {
            "#text": "107", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "August 13, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01669902", 
            "org_study_id": "ML28247"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "lastchanged_date": "May 12, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Esbjerg", 
                        "country": "Denmark", 
                        "zip": "6700"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Holb\u00e6k", 
                        "country": "Denmark", 
                        "zip": "4300"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kolding", 
                        "country": "Denmark", 
                        "zip": "6000"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "K\u00f8ge", 
                        "country": "Denmark", 
                        "zip": "4600"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Svendborg", 
                        "country": "Denmark", 
                        "zip": "5700"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Vejle", 
                        "country": "Denmark", 
                        "zip": "7100"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bergen", 
                        "country": "Norway", 
                        "zip": "5053"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Gjettum", 
                        "country": "Norway", 
                        "zip": "1346"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Moss", 
                        "country": "Norway", 
                        "zip": "1535"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Skien", 
                        "country": "Norway", 
                        "zip": "3722"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Trondheim", 
                        "country": "Norway", 
                        "zip": "7030"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Falun", 
                        "country": "Sweden", 
                        "zip": "SE-791 82"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Farsta", 
                        "country": "Sweden", 
                        "zip": "541 85"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Goteborg", 
                        "country": "Sweden", 
                        "zip": "413 45"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Helsingborg", 
                        "country": "Sweden", 
                        "zip": "251 87"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hudiksvall", 
                        "country": "Sweden", 
                        "zip": "824 81"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "J\u00f6nk\u00f6ping", 
                        "country": "Sweden", 
                        "zip": "551 85"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Karlskrona", 
                        "country": "Sweden", 
                        "zip": "37185"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Karlstad", 
                        "country": "Sweden", 
                        "zip": "65185"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kristianstad", 
                        "country": "Sweden", 
                        "zip": "29185"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Malmo", 
                        "country": "Sweden", 
                        "zip": "205 02"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Simrishamn", 
                        "country": "Sweden", 
                        "zip": "272 81"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Skoevde", 
                        "country": "Sweden", 
                        "zip": "54185"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Trelleborg", 
                        "country": "Sweden", 
                        "zip": "231 85"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Uppsala", 
                        "country": "Sweden", 
                        "zip": "75185"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "V\u00e4ster\u00e5s", 
                        "country": "Sweden", 
                        "zip": "72189"
                    }
                }
            }
        ], 
        "location_countries": {
            "country": [
                "Denmark", 
                "Norway", 
                "Sweden"
            ]
        }, 
        "number_of_groups": "1", 
        "official_title": "HAQIMONO a Non-interventional National Multicenter Study, Observing RA Patients Treated With Tocilizumab in Mono-therapy, i.e. Without Combination With DMARD", 
        "overall_official": {
            "affiliation": "Hoffmann-La Roche", 
            "last_name": "Clinical Trials", 
            "role": "Study Director"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "Sweden: Regional Ethical Review Board"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Proportion of patients on RoActemra/Actemra treatment at 6 months after treatment initiation", 
            "safety_issue": "No", 
            "time_frame": "2 years"
        }, 
        "removed_countries": {
            "country": "United States"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01669902"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Rates of dose modifications/interruptions", 
                "safety_issue": "No", 
                "time_frame": "2 years"
            }, 
            {
                "measure": "Clinical/demographic patient characteristics at initiation of treatment", 
                "safety_issue": "No", 
                "time_frame": "2 years"
            }, 
            {
                "measure": "Efficacy: Response according to total joint count evaluation by DAS28/EULAR/SDAI/CDAI/ACR", 
                "safety_issue": "No", 
                "time_frame": "2 years"
            }, 
            {
                "measure": "Patient recorded outcomes: Health Assessment Questionnaire", 
                "safety_issue": "No", 
                "time_frame": "2 years"
            }, 
            {
                "measure": "Introduction/use of disease-modifying anti-rheumatic drugs (DMARDs)", 
                "safety_issue": "No", 
                "time_frame": "2 years"
            }, 
            {
                "measure": "Safety: Incidence of adverse events", 
                "safety_issue": "No", 
                "time_frame": "2 years"
            }
        ], 
        "source": "Hoffmann-La Roche", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Hoffmann-La Roche", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "April 2012", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "May 2014"
    }
}